Royce & Associates’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,000
| Closed | -$907K | – | 976 |
|
|
2022
Q2 | $907K | Sell |
3,000
-3,000
| -50% | -$907K | 0.01% | 764 |
|
|
2022
Q1 | $2.46M | Hold |
6,000
| – | – | 0.02% | 684 |
|
|
2021
Q4 | $2.81M | Hold |
6,000
| – | – | 0.02% | 672 |
|
|
2021
Q3 | $2.55M | Hold |
6,000
| – | – | 0.02% | 710 |
|
|
2021
Q2 | $2.16M | Hold |
6,000
| – | – | 0.01% | 751 |
|
|
2021
Q1 | $1.69M | Hold |
6,000
| – | – | 0.01% | 783 |
|
|
2020
Q4 | $1.7M | Sell |
6,000
-2,000
| -25% | -$567K | 0.01% | 755 |
|
|
2020
Q3 | $2.2M | Hold |
8,000
| – | – | 0.02% | 661 |
|
|
2020
Q2 | $1.82M | Sell |
8,000
-15,000
| -65% | -$3.41M | 0.02% | 684 |
|
|
2020
Q1 | $3.5M | Hold |
23,000
| – | – | 0.05% | 465 |
|
|
2019
Q4 | $3.46M | Sell |
23,000
-6,000
| -21% | -$902K | 0.03% | 580 |
|
|
2019
Q3 | $4.11M | Hold |
29,000
| – | – | 0.04% | 525 |
|
|
2019
Q2 | $3.63M | Hold |
29,000
| – | – | 0.03% | 571 |
|
|
2019
Q1 | $3.2M | Hold |
29,000
| – | – | 0.03% | 614 |
|
|
2018
Q4 | $2.84M | Buy |
29,000
+6,000
| +26% | +$588K | 0.03% | 628 |
|
|
2018
Q3 | $2.84M | Hold |
23,000
| – | – | 0.02% | 749 |
|
|
2018
Q2 | $2.28M | Hold |
23,000
| – | – | 0.02% | 805 |
|
|
2018
Q1 | $2.03M | Hold |
23,000
| – | – | 0.01% | 852 |
|
|
2017
Q4 | $2.27M | Hold |
23,000
| – | – | 0.02% | 817 |
|
|
2017
Q3 | $2.21M | Hold |
23,000
| – | – | 0.01% | 806 |
|
|
2017
Q2 | $2.17M | Hold |
23,000
| – | – | 0.01% | 826 |
|
|
2017
Q1 | $1.88M | Hold |
23,000
| – | – | 0.01% | 876 |
|
|
2016
Q4 | $1.95M | Buy |
+23,000
| New | +$1.95M | 0.01% | 832 |
|
|
2013
Q4 | – | Sell |
-20,800
| Closed | -$856K | – | 1484 |
|
|
2013
Q3 | $856K | Buy |
20,800
+6,200
| +42% | +$255K | ﹤0.01% | 1195 |
|
|
2013
Q2 | $513K | Buy |
+14,600
| New | +$513K | ﹤0.01% | 1232 |
|